Accelerate complex molecule development by optimizing chemical synthesis and formulation


Innovations in science and technology over the last few decades enable scientists to create far more advanced pharmaceuticals for today’s industry.

As a result, patients rightfully expect medication with fewer side effects and physicians anticipate new and better cures for formerly untreatable diseases. These expectations require new pharmaceuticals to offer an advantage over existing therapies, one that sponsor companies must be able to prove in clinical trials. However, they also increase the difficulties of drug development, due to the added complexity of the active pharmaceutical ingredient (API) and the delivery system needed for these drugs.